Livzon Pharmaceutical Group Inc. (000513)

Overview

Livzon Pharmaceutical Group Inc., established in 1985 and based in Zhuhai, China, is a prominent entity in the pharmaceutical sector. The company is engaged in the research, development, production, export, and sale of pharmaceutical products, along with active pharmaceutical ingredients and intermediates within the People's Republic of China. It boasts a wide spectrum of products catering to various medical conditions, underlining its commitment to enhancing healthcare and medical treatment options.

Products and Services

The company's product and service offerings include:

• Ilaprazole Enteric Coated Tablets: Used for the treatment of duodenal ulcers and reflux esophagitis, showcasing the company's involvement in gastrointestinal health.
• Laprazole Sodium for Injection: Aimed at treating peptic ulcer hemorrhage, this demonstrates Livzon's expertise in developing solutions for acute gastrointestinal conditions.
• Leuprorelin Acetate Microspheres for Injection: Addresses a range of conditions including endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty. It highlights the company's commitment to reproductive and oncological health.
• Urofollitropin for Injection: Treats anovulation and sufferers, catering to fertility issues and indicating the firm's role in reproductive health management.
• Perospirone Hydrochloride Tablets: Used for treating schizophrenia, this product places Livzon in the mental health pharmaceuticals market.
• Shenqi Fuzheng Injection: This treatment aimed at addressing weakness, tiredness, spontaneous sweating, vertigo, and also acts as an adjunct therapy for lung and stomach cancer, showcasing Livzon's approach to integrative medicine and support for cancer patients.
• Anti-viral Granules: For upper respiratory tract infections and influenza, emphasizing the company's contributions to treating viral infections.
• Tocilizumab Injection: This treatment for rheumatoid arthritis underlines Livzon's involvement in autoimmune disease management.
• Recombinant SARS-CoV-2 Fusion Protein Vaccine: A preventive measure against diseases caused by SARS-CoV-2 infection, showcasing Livzon's part in combating the global pandemic.
• Antinuclear Antibody Test Kit: This kit is used for the detection of common anti-nuclear and anti-antibodies in autoimmune diseases, highlighting the company's role in diagnostics.
• Nucleic Acid Test Kits for HIV Type 1 and Interferon-Gamma Release Assays Test Kits: Useful in diagnosing Mycobacterium tuberculosis infection, these kits reinforce Livzon’s capabilities in infectious disease diagnostics.
• Diagnostic Kit for IgM Antibody to Mycoplasma Pneumonia: Further demonstrates the company's strength in developing diagnostic tools for infectious diseases.

Additionally, Livzon Pharmaceutical Group Inc. provides a range of biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics, covering an extensive spectrum of healthcare demands and reinforcing its position as a comprehensive provider of pharmaceutical solutions.